VRTX
Vertex Pharmaceuticals Inc
526.20$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 12.8% | 14.6% | 12.7% | 14.1% | 14.2% | 14.5% | 13.1% | 13.7% | 13.5% | 14.4% | 13.2% | 14.7% | 14.0% | |
| 87.2% | 85.4% | 87.3% | 85.9% | 85.8% | 85.5% | 86.9% | 86.3% | 86.5% | 85.6% | 86.8% | 85.3% | 86.0% | |
| 34.7% | 53.7% | 32.2% | 204.7% | 31.6% | 34.3% | 35.4% | 33.0% | 33.6% | 30.2% | 32.2% | 29.8% | 31.4% | |
| 10.6% | 14.7% | 12.8% | 14.1% | 13.4% | 13.0% | 14.3% | 14.3% | 14.5% | 15.1% | 16.5% | 17.5% | 15.9% | |
| 45.3% | 46.1% | 45.0% | 218.8% | 45.6% | 50.2% | 64.2% | 47.4% | 48.0% | 45.3% | 48.7% | 47.9% | 47.4% | |
| 41.8% | 39.3% | 42.4% | -132.9% | 40.3% | 35.2% | 22.7% | 38.8% | 38.6% | 40.3% | 38.1% | 37.4% | 38.6% | |
| 0.4% | 0.4% | 0.4% | 0.4% | 0.3% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | – | – | – | |
| 47.5% | 45.6% | 47.6% | -128.2% | 44.2% | 39.0% | 26.4% | 43.3% | 42.2% | 41.2% | 41.9% | 41.8% | 41.8% | |
| 5.8% | 7.1% | 6.7% | 7.7% | 6.4% | 7.7% | 3.0% | 8.4% | 7.0% | 4.3% | 7.4% | 8.8% | 6.9% | |
| 41.7% | 38.5% | 40.9% | -135.8% | 37.7% | 31.4% | 23.3% | 34.8% | 35.2% | 36.9% | 34.5% | 33.0% | 34.9% | |
| 49.6% | 48.3% | 50.0% | -125.8% | 46.4% | 40.7% | 28.2% | 45.1% | 44.1% | 43.0% | 43.8% | 41.8% | 43.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.